target

Pionyr Immunotherapeutics

bidder

Gilead Sciences

£221m

24 dealmakers

target

Tizona Therapeutics

bidder

Gilead Sciences

£235m

43 dealmakers

target

Asklepios Biopharmaceutical

bidder

Bayer

£3,051m

38 dealmakers

target

Trillium Therapeutics

bidder

Pfizer

£1,658m

55 dealmakers

target

Triad Life Sciences

bidder

Convatec Group

£335m

18 dealmakers

target

Biohaven Pharmaceutical Holding Company

bidder

Pfizer

£9,417m

45 dealmakers

target

ZYMERGEN

bidder

Ginkgo Bioworks

£249m

63 dealmakers

target

Provention Bio

bidder

Sanofi

£2,408m

76 dealmakers

target

Baxter (biopharma Solutions)

bidder

Warburg Pincus

£3,364m

98 dealmakers

target

Patch Biosciences

bidder

Ginkgo Bioworks

value n/a

25 dealmakers

target

Edwards Lifesciences (critical-care Unit)

bidder

Becton Dickinson & Company

£3,302m

34 dealmakers

target

Agbiome (platform Assets)

bidder

Ginkgo Bioworks

value n/a

8 dealmakers